Pharmacist Responsibility for Screening of Opioid Use in Non-Tolerant Patients

Published: June 7th, 2010

Category: News, Pharmaceutical Outcomes News

W. Thomas “Tommy” Smith, Pharm.D., J.D., a clinical assistant professor of pharmaceutical outcomes and policy has received a one-year award totaling more than $56,600 from Cephalon, Inc. The award supports research conducted by Smith and co-investigator, Professor David Brushwood, R.Ph., J.D., titled Pharmacist Responsibility for Screening of Opioid Use in Non-Tolerant Patients. The study aims to locate and report legal precedents that recognize pharmacists’ responsibility for the screening of opium-based narcotic prescriptions that contain warning labels for patients who may suffer adverse reactions.